Company Overview and News

 
DDB Mudra West launches agency for start-ups

2017-02-28 thehindubusinessline
DDB Mudra West has launched a new agency, Karma, to address the growing number of start-ups and SMEs in the country.

 
Arvind SmartSpaces’ net loss widens in third quarter

2017-01-27 thehindubusinessline
Arvind Group's infrastructure arm Arvind SmartSpaces Ltd (formerly Arvind Infrastructure Ltd) posted net loss of ₹1.39 crore for the third quarter ended December 2016 against loss of ₹0.57 crore in the same quarter last fiscal.

 
No let-up in FPI selling; 353 stocks hit the lower circuit

2016-11-21 thehindubusinessline
There is no respite in selling by foreign institutional investors. Their fury took a heavy toll on several mid- and small-cap stocks, many of which are at 52-week lows.

 
 
Arvind Infrastructure in the black, posts Rs 2.3 cr net profit in Q2

2016-10-26 thehindubusinessline
Arvind group's infrastructure arm, Arvind Infrastructure Ltd, on Wednesday posted a standalone net profit of Rs 2.29 crore for the quarter ended September 2016 as against a net loss of Rs 0.24 crore in the same quarter last year.

 
 
Arvind to sell 10% stake in brands business to Multiples PE for Rs740 crore

2016-10-25 livemint
The brands business is the second asset after real estate that Arvind is unlocking to create shareholder value

 
Results of Canara Bank, ITC, HUL, Hero MotoCorp, HDFC

2016-10-25 thehindubusinessline
Ajanta Pharma, Cadila Healthcare, Canara Bank, Cummins India, Dabur India, Dalmia Bharat, Deepak Nitrite, Arvind Infrastructure, Excel Crop, Exide, Indoco Remedies, HDFC, Hindustan Unilever, Hero MotoCorp, ITC, JSW Energy, JK Lakshmi Cement, Just Dial, Jubilant Foodworks, LMW (also buyback), Raymond, R Systems, Syndicate Bank, Thomas Cook and Union Bank of India are among the companies that will declare their July-September results on Wednesday.

 
Arvind Infrastructure Limited - Results

2016-10-18 feedproxy.google

 
 

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

2018-05-21 - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

2018-05-21 - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...